Frankfurt - Delayed Quote EUR
Revvity, Inc. (PKN.F)
81.00
+0.14
+(0.17%)
As of 3:59:53 PM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 14 | 12 | 15 | 15 |
| Avg. Estimate | 661.66M | 709.58M | 2.83B | 3.01B |
| Low Estimate | 656.85M | 702M | 2.82B | 2.96B |
| High Estimate | 665M | 716.13M | 2.84B | 3.06B |
| Year Ago Sales | 650.13M | 691.89M | 2.76B | 2.83B |
| Sales Growth (year/est) | 1.77% | 2.56% | 2.78% | 6.23% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PKN.F | -- | -- | -- | -- |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Upgrades & Downgrades
| Maintains | Baird: Outperform to Outperform | 4/21/2025 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 4/17/2025 |
| Maintains | Barclays: Overweight to Overweight | 4/10/2025 |
| Maintains | Barclays: Overweight to Overweight | 2/3/2025 |
| Reiterates | Raymond James: Outperform to Outperform | 2/3/2025 |
| Maintains | Keybanc: Overweight to Overweight | 2/3/2025 |